Michele McElvain

615 total citations
15 papers, 345 citations indexed

About

Michele McElvain is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Michele McElvain has authored 15 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Immunology. Recurrent topics in Michele McElvain's work include CAR-T cell therapy research (7 papers), Sphingolipid Metabolism and Signaling (5 papers) and Immune Cell Function and Interaction (3 papers). Michele McElvain is often cited by papers focused on CAR-T cell therapy research (7 papers), Sphingolipid Metabolism and Signaling (5 papers) and Immune Cell Function and Interaction (3 papers). Michele McElvain collaborates with scholars based in United States. Michele McElvain's co-authors include P Hunt, Stephen A. Kaufman, Esther Choi, Han Xu, Min Wong, Mike Frohn, Matthew Adlam, Roland W. Bürli, Jennifer E. Golden and Vellarkad N. Viswanadhan and has published in prestigious journals such as Journal of Nutrition, Science Translational Medicine and Stem Cells.

In The Last Decade

Michele McElvain

14 papers receiving 335 citations

Peers

Michele McElvain
Mark Ma United States
Thomas Horn United States
Fanjun Cheng China
Ngin Cin Khai Japan
Stephanie Nguyen Australia
Sabine Häcker Germany
Hui Jin Japan
D Chatterjee United States
Laurène Froment Switzerland
Yael Zimra Israel
Mark Ma United States
Michele McElvain
Citations per year, relative to Michele McElvain Michele McElvain (= 1×) peers Mark Ma

Countries citing papers authored by Michele McElvain

Since Specialization
Citations

This map shows the geographic impact of Michele McElvain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele McElvain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele McElvain more than expected).

Fields of papers citing papers by Michele McElvain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele McElvain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele McElvain. The network helps show where Michele McElvain may publish in the future.

Co-authorship network of co-authors of Michele McElvain

This figure shows the co-authorship network connecting the top 25 collaborators of Michele McElvain. A scholar is included among the top collaborators of Michele McElvain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele McElvain. Michele McElvain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Martire, Sara, Michele McElvain, Thomas J. Gill, et al.. (2024). High‐throughput screen to identify and optimize NOT gate receptors for cell therapy. Cytometry Part A. 105(10). 741–751. 1 indexed citations
2.
Wang, Xueyin, Lu Min Wong, Michele McElvain, et al.. (2022). A rational approach to assess off-target reactivity of a dual-signal integrator for T cell therapy. Toxicology and Applied Pharmacology. 437. 115894–115894. 6 indexed citations
3.
Sandberg, Mark L., Michele McElvain, Sanam Shafaattalab, et al.. (2022). A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo. Science Translational Medicine. 14(634). eabm0306–eabm0306. 41 indexed citations
4.
Wang, Xueyin, Michele McElvain, Julyun Oh, et al.. (2021). Extensive functional comparisons between chimeric antigen receptors and T cell receptors highlight fundamental similarities. Molecular Immunology. 138. 137–149. 6 indexed citations
5.
Wang, Xueyin, Mark L. Sandberg, Michele McElvain, et al.. (2021). Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers. Journal of Immunotherapy. 44(8). 292–306. 19 indexed citations
6.
Han, Xu, Agnes E. Hamburger, Xueyin Wang, et al.. (2020). Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigen. Molecular Immunology. 126. 56–64. 14 indexed citations
7.
Wang, Xueyin, Xu Han, Alexander Kamb, et al.. (2020). 125 Reexamination of MAGE-A3 as a T-cell Therapeutic Target. Regular and Young Investigator Award Abstracts. A76.1–A76. 1 indexed citations
8.
Xu, Han, Michele McElvain, Mike Fiorino, et al.. (2013). Predictability of Peripheral Lymphocyte Reduction of Novel S1P1 Agonists by In Vitro GPCR Signaling Profile. SLAS DISCOVERY. 18(9). 997–1007. 3 indexed citations
9.
Frohn, Mike, Victor J. Cee, Brian A. Lanman, et al.. (2011). Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: Potent S1P1 agonists with in vivo lymphocyte-depleting activity. Bioorganic & Medicinal Chemistry Letters. 22(1). 628–633. 9 indexed citations
10.
Reed, Anthony B., Brian A. Lanman, Susana Neira, et al.. (2011). Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groups. Bioorganic & Medicinal Chemistry Letters. 22(4). 1779–1783. 5 indexed citations
11.
Harrington, Paul E., Christopher Fotsch, Mike Frohn, et al.. (2011). Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core. ACS Medicinal Chemistry Letters. 3(1). 74–78. 13 indexed citations
12.
Pennington, Lewis D., Kelvin Sham, Alexander J. Pickrell, et al.. (2011). 4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P1. ACS Medicinal Chemistry Letters. 2(10). 752–757. 12 indexed citations
13.
Bürli, Roland W., Han Xu, Xiaoming Zou, et al.. (2006). Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters. 16(14). 3713–3718. 103 indexed citations
14.
Hunt, P, et al.. (1997). Osteoblast Precursor Cells are Found in CD34 + Cells from Human Bone Marrow. Stem Cells. 15(5). 368–377. 92 indexed citations
15.
Kipp, Deborah E., Corina Grey, Michele McElvain, et al.. (1996). Long-Term Low Ascorbic Acid Intake Reduces Bone Mass in Guinea Pigs. Journal of Nutrition. 126(8). 2044–2049. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Ma Breakdown of academic impact, for papers by Thomas Horn Breakdown of academic impact, for papers by Fanjun Cheng Breakdown of academic impact, for papers by Ngin Cin Khai Breakdown of academic impact, for papers by Stephanie Nguyen Breakdown of academic impact, for papers by Sabine Häcker Breakdown of academic impact, for papers by Hui Jin Breakdown of academic impact, for papers by D Chatterjee Breakdown of academic impact, for papers by Laurène Froment Breakdown of academic impact, for papers by Yael Zimra
Rankless by CCL
2026